Asset Management One Co. Ltd. Has $3.66 Million Stock Position in Solventum Co. (NYSE:SOLV)

Asset Management One Co. Ltd. increased its stake in Solventum Co. (NYSE:SOLV) by 2.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 54,877 shares of the company’s stock after acquiring an additional 1,280 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Solventum were worth $3,662,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the business. PrairieView Partners LLC increased its holdings in Solventum by 3.6% in the fourth quarter. PrairieView Partners LLC now owns 9,530 shares of the company’s stock worth $629,000 after purchasing an additional 334 shares in the last quarter. Van ECK Associates Corp increased its holdings in Solventum by 28.7% in the fourth quarter. Van ECK Associates Corp now owns 47,224 shares of the company’s stock worth $3,120,000 after purchasing an additional 10,530 shares in the last quarter. Kentucky Trust Co bought a new stake in Solventum in the fourth quarter worth approximately $54,000. Stonebridge Financial Group LLC bought a new stake in Solventum in the fourth quarter worth approximately $26,000. Finally, Savant Capital LLC increased its holdings in Solventum by 6.3% in the fourth quarter. Savant Capital LLC now owns 3,914 shares of the company’s stock worth $259,000 after purchasing an additional 233 shares in the last quarter.

Wall Street Analyst Weigh In

Several research firms have recently commented on SOLV. Morgan Stanley boosted their price objective on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Mizuho began coverage on Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective for the company. Finally, Piper Sandler boosted their price objective on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, November 8th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $68.29.

Solventum Stock Performance

Shares of Solventum stock opened at $73.97 on Thursday. The stock has a fifty day simple moving average of $70.98 and a 200 day simple moving average of $68.91. Solventum Co. has a 12-month low of $47.16 and a 12-month high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.